![](/img/cover-not-exists.png)
Do we need to change to VEPEMB chemotherapy in patients 60 years of age and over with Hodgkin's Lymphoma?
Renninson, Emily, Benstead, KimVolume:
31
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2019.09.017
Date:
October, 2019
File:
PDF, 46 KB
2019